Showing results (21-30 of 256) with videos related to

Sort By:
Pageof 26
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1991
Prospective multicenter trial for the response-adapted treatment of high-grade malignant non-Hodgkin's lymphomas: updated results of the COP-BLAM/IMVP-16 protocol with randomized adjuvant radiotherapyM Engelhard, P Meusers, G Brittinger, et al.
British Journal of Cancer|September 29, 2005
Minichromosome maintenance protein 6, a proliferation marker superior to Ki-67 and independent predictor of survival in patients with mantle cell lymphomaC Schrader, D Janssen, W Klapper, et al.
Klinische Wochenschrift|June 1, 1987
Amphotericin-B nephrotoxicity in humans decreased by sodium supplements with coadministration of ticarcillin or intravenous salineR A Branch, E K Jackson, E Jacqz, et al.
Onkologie|February 1, 1988
[Multicenter prospective risk-adapted study on the therapy of non-Hodgkin's lymphomas of high malignancy. Use of COP-BLAM/IMVP-16 and randomized adjuvant radiotherapy--study concept and preliminary results]W Siegert, D Huhn, A Neubauer, et al.
Hematological Oncology|September 1, 1989
Multicentre randomized therapeutic trial for advanced centrocytic lymphoma: anthracycline does not improve the prognosisP Meusers, M Engelhard, H Bartels, et al.
Onkologie|February 1, 1989
[Risk-adapted therapy of highly malignant non-Hodgkin's lymphomas with COP-BLAM/IMVP-16: a prospective multicenter study]H H Gerhartz, W Wilmanns, G Brittinger, et al.
Klinische Wochenschrift|September 15, 1987
Lupus anticoagulant associated syndrome in benign and malignant systemic disease--analysis of ten observationsU Dührsen, D Paar, C Kölbel, et al.
Hematological Oncology|July 1, 1984
Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas results of a prospective multicenter study by the Kiel Lymphoma Study GroupG Brittinger, H Bartels, H Common, et al.
European Journal of Haematology|March 1, 1995
Deep venous thrombosis and pulmonary artery embolism in high-grade non Hodgkin's lymphoma: incidence, causes and prognostic relevanceH Ottinger, C Belka, G Kozole, et al.
Blood|October 15, 1993
Randomized, double-blind, placebo-controlled, phase III study of recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to induction treatment of high-grade malignant non-Hodgkin's lymphomasH H Gerhartz, M Engelhard, P Meusers, et al.
Pageof 26